Batrevac 2010 Injektionsvätska, suspension, förfylld spruta

Country: Sweden

Language: Swedish

Source: Läkemedelsverket (Medical Products Agency)

Active ingredient:

influensavirus A/California/7/2009 (H1N1)-deriverad stam (NYMC X-181), spjälkat virus, inaktiverat; influensavirus A/Perth/16/2009 (H3N2)-liknande stam (NYMC X-187, deriverad från A/Victoria/210/2009), spjälkat virus, inaktiverat; influensavirus B/Brisbane/60/2008-liknande stam (B/Brisbane/60/2008), ytantigen, inaktiverat

Available from:

Abbott Biologicals B.V.

ATC code:

J07BB02

INN (International Name):

the influenza virus A/California/7/2009 (H1N1)-derived strain (NYMC X-181), spjälkat virus, inactivated; influenza virus, A/Perth/16/2009 (H3N2)-like strain (NYMC X-187, derived from A/Victoria/210/2009), spjälkat virus, inactivated; influenza virus, B/Brisbane/60/2008-like strain (B/Brisbane/60/2008), the surface antigen, inactivated

Pharmaceutical form:

Injektionsvätska, suspension, förfylld spruta

Composition:

influensavirus A/California/7/2009 (H1N1)-deriverad stam (NYMC X-181), spjälkat virus, inaktiverat 15 mikrog Aktiv substans; influensavirus B/Brisbane/60/2008-liknande stam (B/Brisbane/60/2008), ytantigen, inaktiverat 15 mikrog Aktiv substans; influensavirus A/Perth/16/2009 (H3N2)-liknande stam (NYMC X-187, deriverad från A/Victoria/210/2009), spjälkat virus, inaktiverat 15 mikrog Aktiv substans

Prescription type:

Receptbelagt

Therapeutic area:

spjälkat virus eller ytantigen

Authorization status:

Avregistrerad

Authorization date:

2000-06-30